Filing Flows › Anika Therapeutics (ANIK) › Q2 2026 › vs Q2 2025
Anika Therapeutics (ANIK) Q2 2026 vs Q2 2025 (year over year)
Anika Therapeutics's revenue rose $4.4M (+16%) from $28.2M in Q2 2025 to $32.6M in Q2 2026. The biggest changes: OEM Channel +$2.4M (+14%); Commercial Channel +$2.0M (+17%). Gross margin 65.1% against 50.9% (+14.2 pts).
Anika Therapeutics, Q2 2026: revenue $32.6M (+16% year over year), operating margin 9.1%, net earnings $3.3M, operating cash flow −$684K. The chart draws each line against Q2 2025, the increases inside each band.
Margins
| Q2 2026 | Q2 2025 | Change | |
|---|---|---|---|
| Gross margin | 65.1% | 50.9% | +14.2 pts |
| Operating margin | 9.1% | -14.8% | +23.9 pts |
| Net margin | 10.1% | -14.1% | +24.2 pts |
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| OEM Channel | $18.7M | $16.3M | $2.4M | +14% |
| Commercial Channel | $13.9M | $11.9M | $2.0M | +17% |
| Revenue | $32.6M | $28.2M | $4.4M | +16% |
| Gross profit | $21.2M | $14.4M | $6.9M | +48% |
| Cost of revenue | $11.4M | $13.9M | −$2.5M | -18% |
| Other income, net | $426K | $891K | −$465K | -52% |
| Operating profit | $3.0M | −$4.2M | $7.1M | — |
| Operating expenses | $18.3M | $18.5M | −$253K | -1% |
| Pre-tax earnings | $3.4M | −$3.3M | $6.7M | — |
| Research & development | $7.3M | $6.3M | $1.0M | +16% |
| SG&A | $10.9M | $12.2M | −$1.3M | -10% |
| Net earnings | $3.3M | −$4.0M | $7.3M | — |
| Income tax | $71K | $681K | −$610K | -90% |
| Operating cash sources | $7.3M | $47K | $7.3M | 156× |
| Depreciation & amortization | $1.5M | $1.3M | $225K | +18% |
| Share-based compensation | $1.8M | $2.5M | −$715K | -28% |
| Cash used in operations | $684K | $189K | $495K | +262% |
| Working capital & other | $7.3M | $47K | $7.3M | 156× |
Questions
How much did Anika Therapeutics's revenue grow year over year in Q2 2026?
Anika Therapeutics's revenue rose $4.4M (+16%) from $28.2M in Q2 2025 to $32.6M in Q2 2026.
What drove Anika Therapeutics's revenue change in Q2 2026?
OEM Channel +$2.4M (+14%); Commercial Channel +$2.0M (+17%).